Improved Diagnostic Tests (e.g., C6 peptide ELISA)

Type: diagnostic

Status: FDA Approved

Developer: Various (e.g., Immunetics)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026